Caprini Score in Venous Surgery: a Prospective Cohort Study

Sponsor
Pirogov Russian National Research Medical University
Study ID
NCT03041805
Status
Recruiting
Apply to this trial

Conditions

  • Varicose Veins
  • Venous Thromboembolism

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • EVLT — PROCEDURE
    Endovenous laser treatment of great saphenous vein, small saphenous vein, accessorial saphenous vein with different laser wavelength and any bare type
  • RFA — PROCEDURE
    Radiofrequency ablation of great saphenous vein, small saphenous vein, accessorial saphenous vein with ClosureFast technique
  • USFS — PROCEDURE
    Ultrasound guided foam sclerotherapy of great saphenous vein, small saphenous vein, accessorial saphenous vein with polidocanol or tetradecyl sulphate of any concentration
  • HL/stripping — PROCEDURE
    High ligation and stripping of great saphenous vein, small saphenous vein, accessorial saphenous vein
  • Miniphlebectomy — PROCEDURE
    Miniphlebectomy of any varicose veins under local, regional or general anaesthesia
  • Sclerotherapy — PROCEDURE
    Foam or liquid sclerotherapy of any varicose veins with polidocanol or tetradecyl sulphate of any concentration
  • GCS — DEVICE
    Graduated compression stockings may be used after procedure by the decision of the doctor
  • LMWH — DRUG
    Low-molecular-weight heparin may be used after procedure by the decision of the doctor

Study Details

The aim of the study is to make a validation of Caprini score in patients undergoing varicose veins surgery, especially endovascular procedures (endovascular laser treatment - EVLT, radiofrequency ablation - RFA, ultrasound-guided foam sclerotherapy - USFS) and to identify patients with elevated risk of postoperative venous thromboembolism (VTE) who will benefit from prophylactic anticoagulation.

Key Dates

First listed
Feb 3, 2017
Start date
Jan 1, 2017
Status verified
Feb 2026
Primary completion
Jan 1, 2027
Completion
Jan 1, 2027

Study Design

Enrollment
3,000 participants (estimated)

Primary Outcome Measure

any episode of VTE [ Time Frame: 0-4 weeks after procedure ]

Central Contacts

Related Studies